No Prescription |
 |
 | ||
|
Bactroban |
|
| ||
No Prescription » Prescription Drugs 2 » Bactroban Mupirocin is used to treat certain skin infections (e.g. impetigo). It is an antibiotic that works by stopping the growth of certain bacteria.How to use Mupirocin TopUse this medication only on the skin. Clean and dry the affected area first. Then apply a small amount of ointment to the area 3 times a day or as directed by your doctor. You may cover the treated area with a bandage.Use this medication regularly in order to get the most benefit from it. Continue to use it for the full amount of time prescribed. Stopping the medication too early may allow bacteria to continue to grow which may result in a relapse of the infection.Avoid using this medication around your eyes nose mouth or on large areas of damaged or broken skin unless otherwise directed by your doctor.Inform your doctor if your condition does not improve in 3-5 days. Buy Bactroban and other Prescription Drugs 2 products online at Medstore. Buy Online at Medstore - Click Here!
About Bactroban: Product Type: Prescription Drugs 2 Bactroban/T-Bact Ointment ( Generic Mupirocin ) Bactroban/T-Bact Ointment (Generic Mupirocin) Generic Mupirocin 2%w/v 15gm (3 x 5gm) 5gm Generic Mupirocin Bactroban/T-Bact Ointment
View more Prescription Drugs 2 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
